… has been identified in the 3' untranslated region of the prothrombin gene (… factor of 2.7 to
3.8. The expected prevalence of both the factor V Leiden mutation and the prothrombin mutation …

… Since the ACV test has been previously shown to have a 100% predictive value in screening
for protein C deficiencies and for Factor Leiden mutation 18 , it was used in the present …

… this study, neither factor V Leiden nor the prothrombin variant (G20210A) was an important
risk factor for stroke in young women. In this setting, screening for these mutations cannot be …

… prothrombin G20210A mutation … mutation (8 versus 15%, P = 0.134, odds ratio: 0.4, 95%
CI: 0.1–1.2). Our results suggest that the presence of factor V Leiden and prothrombin G20210A …

… prevalence of prothrombin G20210A and factor V G1691A (R506Q, FV-Leiden) mutations
in … to recommend management for high-risk mutation carriers. One hundred ten women with …

… Prothrombin G20210A mutation The pooled analysis of studies investigating an association
between the prothrombin G20210A mutation … the prothrombin G20210A mutation and overall …

… FVL and the prothrombin G20210A mutation compared with mutation-free control patients.
Overall, 10 double-heterozygous individuals had 4 recurrent events and 833 mutation-free …

… In this study, authors found that third-trimester nonrecurrent fetal loss associated with FV-Leiden
and FII G20210A mutations but these mutations have no role in second-trimester …

… of the G20210A mutation in the … mutation G20210A is reported from 0% to 15.9% among
ethnic groups [20]. Considering that the factor V mutation G1691A and PTG mutation G20210A …

… The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor
V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341: 801-6. …